Publicaciones en las que colabora con Rafael Carmena Rodríguez (5)

2013

  1. A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs

    Annals of Clinical Psychiatry, Vol. 25, Núm. 1, pp. 17-26

2012

  1. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study

    European Psychiatry, Vol. 27, Núm. 4, pp. 267-274

2008

  1. A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study

    Schizophrenia Research, Vol. 104, Núm. 1-3, pp. 1-12

  2. Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study

    Schizophrenia Research, Vol. 99, Núm. 1-3, pp. 23-28

2007

  1. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study

    Schizophrenia Research, Vol. 90, Núm. 1-3, pp. 162-173